UCB at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

UCB takes part in 2 sessions at FoG London 2027 in London. Its sessions cover AI and data in drug development. Concrete topics include synthetic data as a source of evidence in clinical development and whether AI is delivering real breakthroughs or just faster trial and error.

OrganizationFoG London 2027 Attendance
UCB
Brussels, Belgium
Large pharma
Belgian biopharmaceutical company developing medicines for neurology and immunology conditions.
Panel
Thu Jan 28
11:30–12:00
Are We Seeing Real Breakthroughs from AI, or Just Faster Trial and Error?
Whether AI-discovered drugs now reaching mid-stage trials are truly better molecules, and how success for AI in drug discovery should be measured.
with GSK, Ipsen, Entelo Bio +1 more
Talk
Thu Jan 28
16:10–16:40
Synthetic Data in Clinical Development: Enabling the Next Generation of Scientific Evidence
How industry and regulators are setting rules for using synthetic, computer-generated data in drug development, from trial design to hard-to-study patient groups.
Also
Presenting at the meeting, beyond the sessions above

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UCB

Tell us what you sell and we’ll find the people at UCB most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction